Edward J. Dulac III, EVP, CFO: Intellia Therapeutics NTLA Planned sale · Filed 07/02

Trade details

Type: Planned sale notice
Stock: Intellia Therapeutics NTLA
Person: Edward J. Dulac IIIEVP, CFO
Planned sale date: 26/07/02
Filed: 26/07/02

$80.6K to be sold

Intellia Therapeutics trades, last 26 weeks

What else happened in Intellia Therapeutics around then

Filed or reported within 30 days of the trade day · 06/02~08/01

Edward J. Dulac III's recent trades

Edward J. Dulac IIIEVP, CFO
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$58.8K
6,379 sh
$58.8K
Filed 01/07
Traded 01/05
Edward J. Dulac IIIEVP, CFO
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$104.6K
7,462 sh
$104.6K
Filed 25/07/25
Traded 25/07/23
Edward J. Dulac IIICFO
Sell10b5-1 planFate Therapeutics
Sell10b5-1 plan
Fate Therapeutics
FATE
$19K
2,447 sh
$19K
Filed 24/03/05
Traded 24/03/04
Edward J. Dulac IIICFO
Sell10b5-1 planFate Therapeutics
Sell10b5-1 plan
Fate Therapeutics
FATE
$9,245
1,849 sh
$9,245
Filed 24/01/30
Traded 24/01/29
Edward J. Dulac IIICFO
SellFate Therapeutics
Sell
Fate Therapeutics
FATE
$30.7K
7,028 sh
$30.7K
Filed 24/01/10
Traded 24/01/09